組織因子凝固機能の制御における膜リン脂質
Shabbir A Ansari1, Mohini Mendiratta2, Atrayee Bhattacharya1
1Department of Cellular and Molecular Biology, The University of Texas at Tyler School of Medicine, The University of Texas at Tyler Health Science Center, Tyler, Texas, USA.
Current opinion in hematology
|March 2, 2026
まとめ
膜脂質リモデリングは、組織因子(TF)活性化の鍵であり、TFを不活性状態から活性状態へと移行させる。このリン脂質依存性の復号化を理解することは、新たな血栓症治療戦略にとって不可欠である。
科学分野:
- 生化学
- 細胞生物学
- 止血
背景:
- 組織因子(TF)は伝統的に主にタンパク質間相互作用によって調節されると考えられてきた。
- 膜脂質環境がTF活性の調節に重要な役割を果たすという新たな証拠が登場している。
研究 の 目的:
- TF調節に関する現在の理解を統合し、膜脂質リモデリングを強調する。
- 最近の生物物理学的および機能的研究に基づいてTF凝固機能のメカニズムモデルを更新する。
主な方法:
- TFと脂質の相互作用に関する生物物理学的、メカニズム的、機能的研究のレビュー。
- 高解像度イメージングおよび分子動力学シミュレーションの分析。
- リン脂質リモデリングとそのTF活性への影響に関するデータの統合。
主要な成果:
- TFは低活性の暗号化された状態で存在し、活性化には膜再編成が必要である。
- ホスファチジルセリンの外在化やスフィンゴミエリン加水分解を含むリン脂質リモデリングがTFの復号化を促進する。
- 脂質調節は、タンパク質と脂質の相互作用、膜の湾曲、マイクロドメインを変化させ、凝固因子の配列を最適化する。
結論:
- 膜リン脂質は、正常および疾患状態の両方においてTF機能の活性調節因子である。
- リン脂質依存性のTF復号化経路を定義することは、将来の凝固研究にとって極めて重要である。
- 膜駆動型TF活性を標的とすることは、新規の抗血栓療法のための可能性を提供する。
関連する概念動画
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K
Extrinsic and Intrinsic Pathways of Hemostasis
14.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
14.2K
Clot Retraction and Fibrinolysis
9.7K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
9.7K
Coagulation
11.3K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
11.3K
Phosphoinositides and PIPs
10.4K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
10.4K
Asymmetric Lipid Bilayer
10.5K
Biological membranes show uneven distribution of different types of lipids in the inner and outer layers, resulting in transverse asymmetric membranes. The treatment of the erythrocyte membrane with the enzyme phospholipase confirmed the asymmetric nature of the lipid bilayer. The enzyme hydrolyzes lipids into fatty acids and hydrophilic groups. The phospholipase acts only on the outer layer of the membrane, while the inner layer remains intact. The phospholipase treatment resulted in 80%...
10.5K


